Is CD34 truly a negative marker for mesenchymal stromal cells?

Cytotherapy

Volumn 14, Issue 10, 2012, Pages 1159-1163

  Lin, Ching Shwun ^a   Ning, Hongxiu ^a   Lin, Guiting ^a   Lue, Tom F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adipose; bone marrow; CD34; mesenchymal stromal cell; mesenchymal stromal cell marker; Stro 1

Indexed keywords

CD34 ANTIGEN; CELL MARKER; PLASTIC;

ANTIGEN EXPRESSION; BONE MARROW CELL; CELL ADHESION; CELL CULTURE; COLONY FORMING UNIT; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STROMA CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY;

EID: 84867657863     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2012.729817     Document Type: Article

References (56)

1. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006; 119: 2204-13.
2. Lin CS, Lue TF. Adipose-derived stem cells: Characterization and application in urology. In: Illouz YG, Sterodimas A. Adipose Stem Cells and Regenerative Medicine. New York, NY: Springer; 2011. p. 193-207.
3. Lin CS, Lue TF. Adipose-derived stem cells: Therapy through paracrine actions. In: Hayat MA. Stem Cells and Cancer Stem Cells. New York, NY: Springer; 2012. p. 203-16.
4. Gimble JM, Katz A J, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007; 100: 1249-60.
5. Lin G, Garcia M, Ning H, Banie L, Guo YL, Lue T F, et al. Defining stem and progenitor cells within adipose tissue. Stem Cells Dev. 2008; 17: 1053-63.
6. Zimmerlin L, Donnenberg V S, Pfeifer M E, Meyer E M, Peault B, Rubin JP, et al. Stromal vascular progenitors in adult human adipose tissue. Cytometry A. 2010; 77: 22-30.
7. Maumus M, Peyrafitte JA, D'A ngelo R, Fournier-Wirth C, Bouloumie A, Casteilla L, et al. Native human adipose stromal cells: Localization, morphology and phenotype. Int J Obes (Lond). 2011; 35: 1141-53.
8. Corselli M, Chen C W, Sun B, Yap S, Rubin P J, Peault B. The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev. 2012; 21: 1299-308.
9. Banie L, Wang G, Qiu X, et al. Identification of active and quiescent adipose vascular stromal cells. Cytotherapy. 2012; 14: 240-6.
10. Lin CS, Xin ZC, Deng CH, Ning H, Lin G, Lue T F. Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol. 2010; 25: 807-15.
11. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-7.
12. Furness S G, McNagny K. Beyond mere markers: Functions for CD34 family of sialomucins in hematopoiesis. Immunol Res. 2006; 34: 13-32.
13. Pontikoglou C, Deschaseaux F, Sensebe L, Papadaki HA. Bone marrow mesenchymal stem cells: Biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev. 2011; 7: 569-89.
14. Friedenstein AJ, Gorskaja JF, Kulagina N N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976; 4: 267-74.
15. Pittenger MF, Mackay A M, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-7.
16. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, et al. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem. 2003; 89: 1235-49.
17. Simmons PJ, Torok-Storb B. CD34 expression by stromal precursors in normal human adult bone marrow. Blood. 1991; 78: 2848-53.
18. Kaiser S, Hackanson B, Follo M, Mehlhorn A, Geiger K, Ihorst G, et al. BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype. Cytotherapy. 2007; 9: 439-50.
19. Simmons P J, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood. 1991; 78: 55-62.
20. Lin G, Liu G, Banie L, Wang G, Ning H, Lue TF, et al. Tissue distribution of mesenchymal stem cell marker Stro-1. Stem Cells Dev. 2011; 20: 1747-52.
21. Ning H, Lin G, Lue TF, Lin CS. Mesenchymal stem cell marker Stro-1 is a 75 kd endothelial antigen. Biochem Biophys Res Commun. 2011; 413: 353-7.
22. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: Regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007; 9: 204-13.
23. Watt SM, Karhi K, Gatter K, Furley AJ, Katz FE, Healy LE, et al. Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-1) associated with human hemopoietic progenitor cells. Leukemia. 1987; 1: 417-26.
24. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood. 1990; 75: 2417-26.
25. Muller A M, Hermanns MI, Skrzynski C, Nesslinger M, Muller KM, Kirkpatrick CJ. Expression of the endothelial markers PECAM-1, vWf, and CD34 in vivo and in vitro. Exp Mol Pathol. 2002; 72: 221-9.
26. Testa JE, Chrastina A, Oh P, Li Y, Witkiewicz H, Czarny M, et al. Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo. Am J Physiol Lung Cell Mol Physiol. 2009; 297: L251-62.
27. Unger RE, Krump-Konvalinkova V, Peters K, Kirkpatrick CJ. In vitro expression of the endothelial phenotype: Comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6 R. Microvasc Res. 2002; 64: 384-97.
28. Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, et al. Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives. Circulation. 2004; 109: 656-63.
29. Suga H, Shigeura T, Matsumoto D, Inoue K, Kato H, Aoi N, et al. Rapid expansion of human adipose-derived stromal cells preserving multipotency. Cytotherapy. 2007; 9: 738-45.
30. Mouiseddine M, Mathieu N, Stefani J, Demarquay C, Bertho JM. Characterization and histological localization of multipotent mesenchymal stromal cells in the human postnatal thymus. Stem Cells Dev. 2008; 17: 1165-74.
31. Stolzing A, Bauer E, Scutt A M. Suspension cultures of bone marrow derived mesenchymal stem cells: Effects of donor age and glucose level. Stem Cells Dev. 2012; 21: 2718-23.
32. Copland I, Sharma K, Lejeune L, Eliopoulos N, Stewart D, Liu P, et al. CD34 expression on murine marrow-derived mesenchymal stromal cells: Impact on neovascularization. Exp Hematol. 2008; 36: 93-103.
33. Peister A, Mellad J A, Larson B L, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood. 2004; 103: 1662-8.
34. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996; 273: 242-5.
35. Goodell M A, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, et al. Dye effl ux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 1997; 3: 1337-45.
36. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. Anewly discovered class of human hematopoietic cells with SCIDrepopulating activity. Nat Med. 1998; 4: 1038-45.
37. Morel F, Galy A, Chen B, Szilvassy SJ. Equal distribution of competitive long-term repopulating stem cells in the CD34 -and CD34 -fractions of Thy-1 low Lin -/low Sca-1 -bone marrow cells. Exp Hematol. 1998; 26: 440-8.
38. Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M. Human bone marrow CD34 -cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34 -cells. Exp Hematol. 1998; 26: 353-60.
39. Donnelly DS, Zelterman D, Sharkis S, Krause D S. Functional activity of murine CD34 -and CD34 -hematopoietic stem cell populations. Exp Hematol. 1999; 27: 788-96.
40. Sato T, Laver JH, Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 1999; 94: 2548-54.
41. Lange C, Kaltz C, Thalmeier K, Kolb H J, Huss R. Hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34, Sca-1, Thy-1 (low), c-kit -stem cell line. JHematother Stem Cell Res. 1999; 8: 335-42.
42. Huss R. Isolation of primary and immortalized CD34- hematopoietic and mesenchymal stem cells from various sources. Stem Cells. 2000; 18: 1-9.
43. He Q, Wan C, Li G. Concise review. Multipotent mesenchymal stromal cells in blood. Stem Cells. 2007; 25: 69-77.
44. Gangenahalli GU, Singh VK, Verma YK, Gupta P, Sharma RK, Chandra R, et al. Hematopoietic stem cell antigen CD34: Role in adhesion or homing. Stem Cells Dev. 2006; 15: 305-13.
45. Nielsen J S, McNagny K M. CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Microcirculation. 2009; 16: 487-96.
46. Cheng J, Baumhueter S, Cacalano G, Carver-Moore K, Thibodeaux H, Thomas R, et al. Hematopoietic defects in mice lacking the sialomucin CD34. Blood. 1996; 87: 479-90.
47. Suzuki A, Andrew DP, Gonzalo JA, Fukumoto M, Spellberg J, Hashiyama M, et al. CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein. Blood. 1996; 87: 3550-62.
48. Nielsen JS, McNagny KM. Infl uence of host irradiation on long-term engraftment by CD34-deficient hematopoietic stem cells. Blood. 2007; 110: 1076-7.
49. Suga H, Matsumoto D, Eto H, Inoue K, Aoi N, Kato H, et al. Functional implications of CD34 expression in human adipose-derived stem/progenitor cells. Stem Cells Dev. 2009; 18: 1201-10.
50. Liu JW, Dunoyer-Geindre S, Serre-Beinier V, Mai G, Lambert JF, Fish RJ, et al. Characterization of endothelial-like cells derived from human mesenchymal stem cells. JThromb Haemost. 2007; 5: 826-34.
51. Zhang L, Tang A, Zhou Y, Tang J, Luo Z, Jiang C, et al. Tumor-conditioned mesenchymal stem cells display hematopoietic differentiation and diminished infl ux of Ca(2). Stem Cells Dev. 2012; 21: 1418-28.
52. Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun. 2005; 332: 370-9.
53. Goodell MA. Introduction. Focus on hematology. CD34(-) or CD34(-): Does it really matter? Blood. 1999; 94: 2545-7.
54. Quirici N, Scavullo C, d e Girolamo L, Lopa S, Arrigoni E, Deliliers GL, et al. Anti-L-NGFR and -CD34 monoclonal antibodies identify multipotent mesenchymal stem cells in human adipose tissue. Stem Cells Dev. 2010; 19: 915-25.
55. Ergun S, Tilki D, Klein D. Vascular wall as a reservoir for different types of stem and progenitor cells. Antioxid Redox Signal. 2011; 15: 981-95.
56. Matsumoto T, Ingham SM, Mifune Y, Osawa A, Logar A, Usas A, et al. Isolation and characterization of human anterior cruciate ligament-derived vascular stem cells. Stem Cells Dev. 2012; 21: 859-72.